OpGen (OPGN)
(Delayed Data from OTC)
$2.10 USD
+0.08 (3.96%)
Updated Sep 20, 2024 03:24 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
OpGen, Inc. [OPGN]
Reports for Purchase
Showing records 1 - 20 ( 106 total )
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
3Q23 Financial Results; Update Rating to Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
2Q23 Results; Liquidity Shortfall; Downgrade to Neutral Without PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
FIND collaboration advances to development
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Feasibility milestone from FIND collaboration
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Milestones Met for FIND RD Collaboration; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Genomic AST Patent Maintained Under Opposition in Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Optimized Unyvero A30 Instrument Close to Final Release Version; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Trial Results For Unyvero Urinary Tract Infection Panel Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Optimistic start to kick off a promising year
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
1Q23 Financial Results Reported; Reiterate Buy With $3 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
$3.5m fund-raise to extend runway
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
FIND agreement milestones achieved
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Fisher deal broadens US commercialization opportunity
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Expansion of FIND R&D collaboration
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Interim milestone achieved for R&D collaboration
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
Forecasts reset ahead of busy 2023
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: OpGen, Inc.
Industry: Medical Services
FY22 wrap offers key operational takeaways
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S